First Psychedelics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MindMed (OTCQB:MMEDF) released its full-year 2020 financial results.  The company posted a net and comprehensive loss of $35.1 million for the year ended Dec. 31, 2020. Its total assets at the end of the reporting period were $85.6 million, counting $80.1 million in cash. The company used $24.2 million of net cash in operating activities in 2020. Its cash balance as of Tuesday last week hovered at $161 million. The company plans to use the money to improve its portfolio and develop its technology sector. On Monday, MindMed also revealed the results of a study on personalized MDMA dosing, con...

Field Trip Health, a wholly owned subsidiary of Field Trip Psychedelics, a mental wellness company focused on psychedelics and psychedelic-enhanced psychotherapy, debuted its first medical center in Toronto on Wednesday. The center will be dedicated exclusively to the administration of psychedelic-... Read More... Don't Miss Any Updates! News Directly in Your Inbox Subscribe to:

California’s legislature could soon be discussing a new bill meant to decriminalize psychedelic substances. On Tuesday, State Senator Scott Wiener announced via Twitter his intention to introduce a new bill aimed at pulling back on penalties for the non-commercial use of these drugs, first... Read More... Don't Miss Any Updates! News Directly in Your Inbox Subscribe to:

The Horizons Psychedelic Stock Index ETF is now listed on Toronto’s NEO exchange under the symbol ‘PSYK’, and managed by Horizons ETFs Management. PSYK is a passive ETF, meaning that it’s not actively managed. The ETF follows the North American Psychedelics Index, an index owned and operated by Horizons and Solactive AG, which aims to replicate the performance of North American publicly-listed life sciences companies that are involved in the psychedelics industry. Horizons’ criteria for choosing members of the index requires companies to be listed on a stock exchange in Canada or...

Revive Therapeutics Included in First Psychedelic Exchange Traded Fund Revive Therapeutics Ltd. a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management. The Horizons Psychedelic Stock Index ETF index is expected to … Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life scie...